According to Medical Design, the company is booming and has provided a large amount of supplies to deal with COVID-19. In 2020, Medline's sales were 17.5 billion U.S. dollars, an increase of 25.9% over 2019 sales.
In contrast, in the absence of an epidemic, its revenue increased by 18.8% between 2018 and 2019. Among the 100 largest medical device companies, the company ranks ninth.
According to the top 100 global medical device companies in 2020 (2020 BIG 100) released by the medical device industry website Medical Design & Outsourcing, Medtronic, Johnson & Johnson, and Philips continue to rank among the top three global medical device companies in terms of revenue, with revenues of 289.13 at the company headquarters respectively. Billion U.S. dollars, 25.963 billion U.S. dollars, 21.808 billion U.S. dollars.
Medline's revenue was $13.90 billion, ranking ninth, ahead of Danaher ($13.513 billion) and after Stryker ($14.848 billion).
During the epidemic, Medline expanded its coverage to meet the growing demand for masks and other basic medical equipment, and opened millions of distribution centers in the United States. Medline has also expanded the production capacity of its plant in Lycia Springs, Georgia, to produce 36 million masks per month.
Since 2018, the company's number of employees has remained the same, reporting 27,000 employees.
It is understood that affected by the epidemic, the mask industry has ushered in rapid growth, and many companies have seen a significant increase in their performance. However, as to how big the global mask market is, many data seem to be inconsistent.
According to a report issued by the Tehran Chamber of Commerce, the global mask market has reached 140 billion U.S. dollars in 2020.
However, according to PR Newswire’s September 2020 data, in 2019, the global market for surgical, facial and respiratory masks was valued at US$2.1413 billion, and is expected to reach a value of US$15,696.2 million by 2030. This market will be valued between 2020 and 2030. The compound annual growth rate is 5.7%.
Surgaid Medical (Xiamen) Co., Ltd
Surgaid Medical (Xiamen) Co., Ltd has been committed to surgical product development, production and marketing for 10 more years. Especially minimally invasive surgical products. Such as Disposable Trocar, Linear Cutter Stapler, Circular Stapler, PPH, and so on.
Manufacturing our own Surgical products allows us to have completely control product's design and evolution. We are able to adapt quickly to the constantly evolving healthcare market and offer competitive quality, single-use, cost-effective solutions which directly compete with global market-leaders.
Surgaid products:
Disposable Single Port Endoscopic
disposable trocar kit
Disposable Circumcision Stapler
Laparoscopic Stapler Cartridge
